was ist hier mit...
On June 29, 2017, Atossa Genetics Inc. (the Company) offered to modify the rights (the Temporary Modification) of the holders of the Warrants issued in the public offering the Company completed on April 3, 2017 (the Warrants). In accordance with Sections 2 and 3 of the Warrants, the Temporary Modification included: (a) lowering the exercise price of the Warrants to $0.26 per share, (b) setting the applicable VWAP (as defined in the Warrant) price at $0.52 per share, and (c) allowing for temporary cashless exercise of the Warrants for all holders that accepted the Temporary Modification before 8:00 a.m. Eastern daylight time on June 30, 2017. Holders of Warrants to purchase a total of approximately 3.0 million shares of Common Stock accepted the offer resulting in the cancellation of those warrants and the issuance by the Company of a total of approximately1.5 million shares of Common Stock (including shares held in abeyance in accordance with the following)
secfilings.nasdaq.com/...%20INC&FormType=8-K&View=html